Secondary cardiovascular prevention in patients with previous myocardial infarction: an individualized approach difficult to be tailored

J Cardiovasc Med (Hagerstown). 2020 Aug;21(8):610-612. doi: 10.2459/JCM.0000000000001020.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Myocardial Infarction* / prevention & control
  • Percutaneous Coronary Intervention* / adverse effects
  • Platelet Aggregation Inhibitors
  • Registries
  • Secondary Prevention

Substances

  • Platelet Aggregation Inhibitors